A rapid method for breath analysis in cystic fibrosis patients
- 28 November 2014
- journal article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 34 (4), 745-751
- https://doi.org/10.1007/s10096-014-2286-5
Abstract
For easy handling and speed of lung diseases diagnostics, approaches based on volatile organic compounds (VOCs), including those emitted by pathogenic microorganisms, are considered but currently require considerable sampling efforts. We tested whether easy-to-handle and fast detection of lung infections is possible using solid-phase microextraction (SPME) of 100 ml of exhaled breath. An analytical procedure for the detection of VOCs from the headspace of epithelial lung cells infected with four human pathogens was developed. The feasibility of this method was tested in a cystic fibrosis (CF) outpatient clinic in vivo. Exhaled breath was extracted by SPME and analyzed by gas chromatography–mass spectrometry (GC-MS). The compositions of VOCs released in the infection model were characteristic for all individual pathogens tested. Exhaled breath of CF patients allowed clear distinction of CF patients and controls by their VOC compositions using multivariate analyses. Interestingly, the major specific VOCs detected in the exhaled breath of infected CF patients in vivo differed from those monitored during bacterial in vitro growth. SPME extraction of VOCs from 100 ml of human breath allowed the distinction between CF patients and healthy probands. Our results highlight the importance of assessing the entire pattern of VOCs instead of selected biomarkers for diagnostic purposes, as well as the need to use clinical samples to identify reliable biomarkers. This study provides the proof-of-concept for the approach using the composition of exhaled VOCs in human breath for the rapid identification of infectious agents in patients with lower respiratory tract infections.Keywords
This publication has 28 references indexed in Scilit:
- Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosaBMC Microbiology, 2012
- Developments in novel breath tests for bacterial and fungal pulmonary infectionCurrent Opinion in Pulmonary Medicine, 2012
- Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysisRespiratory Research, 2012
- Potential sources of 2-aminoacetophenone to confound thePseudomonas aeruginosabreath test, including analysis of a food challenge studyJournal of Breath Research, 2011
- Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitroJournal of Microbiological Methods, 2010
- 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lungBMC Pulmonary Medicine, 2010
- Breath biomarkers of active pulmonary tuberculosisTuberculosis, 2010
- Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in childrenClinical and Experimental Allergy, 2009
- Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: Analysis by solid-phase microextraction and gas chromatography–mass spectrometryJournal of Chromatography B, 2009
- Volatile organic compounds in the exhaled breath of young patients with cystic fibrosisEuropean Respiratory Journal, 2006